Literature DB >> 2981368

HTLV-III testing of donor blood imminent; complex issues remain.

M F Goldsmith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981368     DOI: 10.1001/jama.253.2.173

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Internal medicine: antibody testing for the AIDS retrovirus-implications for clinicians.

Authors:  J A McCutchan
Journal:  West J Med       Date:  1985-07

2.  Detection of Chlamydia trachomatis by enzyme immunoassay, immunofluorescence, and cell culture.

Authors:  P Morgan-Capner; P Hudson; J A Cansfield; A Saeed
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

3.  Prevalence of antibody to human T lymphotropic virus type III by risk group and area, United Kingdom 1978-84.

Authors:  P P Mortimer; W J Jesson; E M Vandervelde; M S Pereira
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-20

4.  Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection.

Authors:  R S Smith; R B Naso; J Rosen; A Whalley; Y L Hom; K Hoey; C J Kennedy; J A McCutchan; S A Spector; D D Richman
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

5.  Screening blood donors for human immunodeficiency virus antibody: cost-benefit analysis.

Authors:  R S Eisenstaedt; T E Getzen
Journal:  Am J Public Health       Date:  1988-04       Impact factor: 9.308

6.  Alternative test sequences for HIV screening of donated blood.

Authors:  H H Imrey; B T Williams
Journal:  J Med Syst       Date:  1989-06       Impact factor: 4.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.